Agreement to Settle Androgel Cases Results in Stay of All Lawsuits Against AbbVie in MDL
All AndroGel claims have been stayed by a federal judge following an announcement that parties were close to a global settlement agreement.
All AndroGel claims have been stayed by a federal judge following an announcement that parties were close to a global settlement agreement.
The first Androderm bellwether trial has been cancelled after parties involved in Androderm lawsuits finalized a settlement agreement.
Parties reached a tentative settlement agreement to resolve all Androderm testosterone lawsuits last month, according to a court order which has paused the litigation to give them time to reach…
A federal jury has ruled in favor of AbbVie in the latest AndroGel bellwether lawsuit to go to trial.
A court order indicates that other judges will help in overseeing 19 trials over testosterone injury claims between October 2018 and March 2019.
The first group of 100 Androderm lawsuits are being worked up for testosterone bellwether trials set to begin next year.
A federal judge has set strict discovery schedules for the first AndroGel lawsuits to go to trial, informing the parties that they must be ready for the first case to…
Parties involved in testosterone lawsuits have filed separate lists of potential Androgel claims that could serve as bellwether test trials next year.
A testosterone litigation status conference being held to day will discuss the status of lawsuits moving toward trial in the summer of 2017.
A request for consolidation of all testosterone lawsuits filed in Pennsylvania state courts has been denied.